Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004583546 | SCV005064653 | pathogenic | Hereditary spastic paraplegia 50 | 2023-10-10 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 13-14 of the AP4M1 gene. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to disrupt the C-terminus of the protein. This variant has not been reported in the literature in individuals affected with AP4M1-related conditions. This variant disrupts a region of the AP4M1 protein in which other variant(s) (p.Arg441*) have been determined to be pathogenic (PMID: 26077850, 32979048, 32989326; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |